1. Home
  2. NKTX vs TISI Comparison

NKTX vs TISI Comparison

Compare NKTX & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • TISI
  • Stock Information
  • Founded
  • NKTX 2015
  • TISI 1973
  • Country
  • NKTX United States
  • TISI United States
  • Employees
  • NKTX N/A
  • TISI N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • TISI Other Consumer Services
  • Sector
  • NKTX Health Care
  • TISI Consumer Discretionary
  • Exchange
  • NKTX Nasdaq
  • TISI Nasdaq
  • Market Cap
  • NKTX 131.3M
  • TISI 105.1M
  • IPO Year
  • NKTX 2020
  • TISI N/A
  • Fundamental
  • Price
  • NKTX $1.97
  • TISI $20.32
  • Analyst Decision
  • NKTX Strong Buy
  • TISI
  • Analyst Count
  • NKTX 6
  • TISI 0
  • Target Price
  • NKTX $15.00
  • TISI N/A
  • AVG Volume (30 Days)
  • NKTX 675.7K
  • TISI 24.3K
  • Earning Date
  • NKTX 05-20-2025
  • TISI 05-20-2025
  • Dividend Yield
  • NKTX N/A
  • TISI N/A
  • EPS Growth
  • NKTX N/A
  • TISI N/A
  • EPS
  • NKTX N/A
  • TISI N/A
  • Revenue
  • NKTX N/A
  • TISI $852,272,000.00
  • Revenue This Year
  • NKTX N/A
  • TISI N/A
  • Revenue Next Year
  • NKTX N/A
  • TISI N/A
  • P/E Ratio
  • NKTX N/A
  • TISI N/A
  • Revenue Growth
  • NKTX N/A
  • TISI N/A
  • 52 Week Low
  • NKTX $1.31
  • TISI $6.53
  • 52 Week High
  • NKTX $8.23
  • TISI $26.77
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 53.68
  • TISI 50.50
  • Support Level
  • NKTX $1.81
  • TISI $20.00
  • Resistance Level
  • NKTX $2.16
  • TISI $22.00
  • Average True Range (ATR)
  • NKTX 0.16
  • TISI 1.54
  • MACD
  • NKTX -0.01
  • TISI -0.35
  • Stochastic Oscillator
  • NKTX 38.32
  • TISI 18.98

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

Share on Social Networks: